Improving the diagnosis of severe malaria in African children using platelet counts and plasma <i>Pf</i>HRP2 concentrations.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35857826.
- Also identified by DOI 10.1126/scitranslmed.abn5040 and PMC identifier 7613613.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Severe malaria caused by <i>Plasmodium falciparum</i> is difficult to diagnose accurately in children in high-transmission settings. Using data from 2649 pediatric and adult patients enrolled in four studies of severe illness in three countries (Bangladesh, Kenya, and Uganda), we fitted Bayesian latent class models using two diagnostic markers: the platelet count and the plasma concentration of <i>P. falciparum</i> histidine-rich protein 2 (<i>Pf</i>HRP2). In severely ill patients with clinical features consistent with severe malaria, the combination of a platelet count of ≤150,000/μl and a plasma <i>Pf</i>HRP2 concentration of ≥1000 ng/ml had an estimated sensitivity of 74% and specificity of 93% in identifying severe falciparum malaria. Compared with misdiagnosed children, pediatric patients with true severe malaria had higher parasite densities, lower hematocrits, lower rates of invasive bacterial disease, and a lower prevalence of both sickle cell trait and sickle cell anemia. We estimate that one-third of the children enrolled into clinical studies of severe malaria in high-transmission settings in Africa had another cause of their severe illness.
Medical subject headings
- Malaria
- Malaria, Falciparum